ML
* ASCENTIAL - First day of trading post IPO, priced at 200p, ASCL LN.........
ACTELION - Q4 in line, 2016 guidance implies 10-11% cons u/gs on generics.+3%
YNAP - FY sales 2% ahead of cons, key metrics solid & NaP outperforms.....+2%
COM HEM - Q4 revs broadly in line, as is u/lying EBITDA, reits guide......+1%
SANOFI - EPS a small beat and Lantus sales ahead of ests should reassure..+1%
KINNVEIK - We UPGRADE to BUY, sell off unjustified, PO to SEK 283.........+1%
TUI - Seasonal EBIT loss in line, reiterates FY16 EBIT growth targets...+0.5%
ICAP - Rev growth consistent with MLe, no material update on TLPR deal....u/c
D. BANK - Reassures on ability to pay AT1s, 5y CDS widest since '11 yday..u/c
REDROW - Demand for new homes robust, order book +51% YoY.................u/c
ENEL GREEN POWER - Headlines a touch light, all about Enel bid still......-1%
SECURITAS - Org growth solid but margin miss = EBITDA 3% below cons.......-2%
PMI IM - Headline beat on one-offs, CET1 and div in line but NII weaker.-2-3%
PANDORA - FY EBITDA in line, margin guidance light v cons,buyback smaller.-3%
TOMTOM - Q4 rev in line, FY EBITDA 2% ahead, sees increased investments...-3%
HANDELSBANKEN - PBT 3.4% miss, NII in line and div SEK 6 v 5.83 cons......-3%
SWEDBANK - Board asks CEO Wolfe to step down, clear surprise, initial -ve.-4%
OUTOTEC - adj EBITA 32% light and guide for FY16 EBITA c40m v 64m cons..-5-7%
MainFirst
*SANOFI-Sales 9.28b(9.38),Div 2.93(3),EPS 1.31(1.28),Pharma -4.7%......-1%
*LAFARGEHOLCIM-Receives revised CCI divestment order 4 India...........U/C
*DBK-Says it can pay debts,lender due 2 pay €350m in April.............-2%
*TUI-Sales 3.72b(3.68),Reits o/lk,takes 41.6m charge Hapag-Lloyd.......+1%
*ACTELION-OP 656m(650),NI 552m(548),Rev 2.05b(2.04),Div 1.5(1.4).......+2%
*HANDELSBANKEN-NII 6.97b(6.81),NI 4.5b(4.6),NLL 475m(455)..............+2%
*SWATCH-Swatch and Safilo sign a 5yr cooperation(Swatch Glasses).......U/C
*SCOR-Reinsurance mkt shows signs of levelling out,2016 G/Prem €6bln...-0.5%
*WILLIAM DEMANT/SONOVA-Looking at AudioNova worth €500m................-0.5%
*BCO POP MILANO-Net 86.9m(65),Strong vol grth,CET1 12.2%...............+3%
*TOMTOM-Rev 282m(280),Ebit 0.2m(10.4),EPS 21c(20),Ebitda 123.7m(121)...-2%
*FRAPORT-Negative read across from TUI,Antalya 15% of valuation........-3%
*PANDORA-Ebitda 6.21b(6.21),Net 3.67b(3.87),2016 Rev 19b+(19.9)........-1%
*SECURITAS-Net 668.6m(717),Sales 21b(20.8),Divi 3.5(3.3),EPS 1.84(1.98)-2%
*WIRECARD-Not able to proceed online payments since Saturday...........-3%
*YOOK NET-A-PORTER-Group 2015 Pro-Forma Rev €1.7b,Net Rev +31%.........+3%
*OUTOTEC-Sales 306m(348),sees 2016 sales at €1bln to €1.2bln...........-5%
CSFB
Actelion -1% Sales in-line, core EBIT 4% ahead, core EPS 6.4% ahead
Anglos +1% Kumba numbers better, Kumba makes up 20% of Anglos
Com Hem +2% Revs and EBITDA broadly in line, EBITDA growth accelerated
Deut Bank +1-2% Distributable items are falling so still able to pay coupon
ICAP UNCH Numbers inline, No new news on Tullets merger
Miners M/P Copper +0.30%, Brent -2.90%, Iron Ore Closed, China Closed
Outotec -2-3% Q4 net sales €306m vs cons 348m, FY sales also light
Pandora -1-2% FY net and outlook slightly light, div better, new buyback
Redrow -2-3% H1 revenues 7% miss, operating profit 8% miss, PTP 3% miss
Sanoma UNCH Q4 sales €408m vs cons 415.8m, new credit facility
Sanofi M/P 4Q EPS Beats, Sales Miss; Sees 2016 EPS Broadly Stable
Securitas -2-3% Org growth 7% is good but EBITA number 3% light
SHB UNCH Numbers miss by 4%, NII better, SEK1.5/shr special divi
Solvay +1% CS reinstate with OUTPERFORM (Cytec and volume growth)
Swedbank -2-3% Mr Wolf will step down as President and CEO
TomTom -2-3% Q4 revenues 1% beat, outlook weaker
TUI -2-4% 1Q underlying EBITA loss of 97.3mln vs CS at 87mln
UK retail UNCH UK BRC sales climbed 2.6% y/y in Jan vs previous ok +0.1%
Yoox +1% Revenues +31% to EU1.67b est EU1.64, +21% on LFL basis
ShoreTUI - current winter trading inline,revs +5.4%,EBITDA +7.2%,reits guidance...+1%
TUNGSTEN - trading inline,EBITDA loss of no more than £15m breakeven by 2017.+1%
CAMBIAN - revised EBITDA target misses due to weakness in cost management....-5%
ALLIED MINDS - revs $3.2m vs $7.7m,rev shortfall at RF Biocidics.............-2%
REDROW - H1 revs +8% to
603m.Int divi 4p.Confident statement................UNCH
ICAP - Revs for Q3 5% lower.Market conditions remained challenging...........-4%
SOPHOS - Q3 trading strengthens,reaffirms previously upgraded outlook........+1%
ASSURA - rent roll +1.4% £61.8m, acquisition opportunities rise to £135m...UNCH